⚠️ Research/education only. Statements about this compound haven’t been evaluated by the FDA; it isn’t intended to diagnose, treat, cure, or prevent disease.
Retatrutide
Peptide Bottle
$150.00
- C221H342N46O68
- 39 aa
- Lyophilized powder
Retatrutide (LY3437943) is a synthetic 39-amino-acid, C20 fatty-diacid-acylated peptide engineered as a simultaneous agonist at the GLP-1, GIP, and glucagon receptors. It has been investigated in preclinical and in-vitro model systems as a reference tool compound for studying coordinated triple incretin/glucagon receptor co-activation. Retatrutide is an investigational compound and is not an approved drug.
20mg
Quantity
⚠️ FDA hasn’t evaluated our statements; efficacy isn’t confirmed by FDA—products aren’t intended to diagnose, treat, cure, or prevent disease.